Sihuan Pharmaceutical Holdings Group Ltd. - Product Pipeline Review - 2015

Published: Dec, 2015 | Pages: 46 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Sihuan Pharmaceutical Holdings Group Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Sihuan Pharmaceutical Holdings Group Ltd. - Product Pipeline Review - 2015', provides an overview of the Sihuan Pharmaceutical Holdings Group Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sihuan Pharmaceutical Holdings Group Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Sihuan Pharmaceutical Holdings Group Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Sihuan Pharmaceutical Holdings Group Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Sihuan Pharmaceutical Holdings Group Ltd.'s pipeline products

Reasons to Buy

- Evaluate Sihuan Pharmaceutical Holdings Group Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Sihuan Pharmaceutical Holdings Group Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Sihuan Pharmaceutical Holdings Group Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Sihuan Pharmaceutical Holdings Group Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sihuan Pharmaceutical Holdings Group Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Sihuan Pharmaceutical Holdings Group Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Sihuan Pharmaceutical Holdings Group Ltd. Snapshot 6
Sihuan Pharmaceutical Holdings Group Ltd. Overview 6
Key Information 6
Key Facts 6
Sihuan Pharmaceutical Holdings Group Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products Glance 14
Sihuan Pharmaceutical Holdings Group Ltd. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Sihuan Pharmaceutical Holdings Group Ltd. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Sihuan Pharmaceutical Holdings Group Ltd. - Early Stage Pipeline Products 17
IND/CTA Filed Products/Combination Treatment Modalities 17
Sihuan Pharmaceutical Holdings Group Ltd. - Unknown Stage Pipeline Products 18
Unknown Products/Combination Treatment Modalities 18
Sihuan Pharmaceutical Holdings Group Ltd. - Drug Profiles 19
Phencynonate Hydrochloride 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Cinepazide Mesylate 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
cyclosporine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Anaprazole Sodium 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Benapenem 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Imigliptin Dihydrochloride 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
JK-05 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
KBP-5209 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Janagliflozin 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Pinoxacin Hydrochloride 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
tylerdipine hydrochloride 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
BR-01 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Analysis 33
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products by Target 33
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products by Route of Administration 35
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products by Molecule Type 36
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products by Mechanism of Action 37
Sihuan Pharmaceutical Holdings Group Ltd. - Recent Pipeline Updates 39
Sihuan Pharmaceutical Holdings Group Ltd. - Dormant Projects 42
Sihuan Pharmaceutical Holdings Group Ltd. - Discontinued Pipeline Products 43
Discontinued Pipeline Product Profiles 43
cyclosporine 43
Sihuan Pharmaceutical Holdings Group Ltd. - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 45
Disclaimer 46

List of Tables

Sihuan Pharmaceutical Holdings Group Ltd., Key Information 6
Sihuan Pharmaceutical Holdings Group Ltd., Key Facts 6
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline by Indication, 2015 9
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline by Stage of Development, 2015 10
Sihuan Pharmaceutical Holdings Group Ltd. - Monotherapy Products in Pipeline, 2015 11
Sihuan Pharmaceutical Holdings Group Ltd. - Partnered Products in Pipeline, 2015 12
Sihuan Pharmaceutical Holdings Group Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 13
Sihuan Pharmaceutical Holdings Group Ltd. - Phase III, 2015 14
Sihuan Pharmaceutical Holdings Group Ltd. - Phase II, 2015 15
Sihuan Pharmaceutical Holdings Group Ltd. - Phase I, 2015 16
Sihuan Pharmaceutical Holdings Group Ltd. - IND/CTA Filed, 2015 17
Sihuan Pharmaceutical Holdings Group Ltd. - Unknown, 2015 18
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline by Target, 2015 34
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline by Route of Administration, 2015 35
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline by Molecule Type, 2015 36
Sihuan Pharmaceutical Holdings Group Ltd. - Pipeline Products by Mechanism of Action, 2015 38
Sihuan Pharmaceutical Holdings Group Ltd. - Recent Pipeline Updates, 2015 39
Sihuan Pharmaceutical Holdings Group Ltd. - Dormant Developmental Projects,2015 42
Sihuan Pharmaceutical Holdings Group Ltd. - Discontinued Pipeline Products, 2015 43
Sihuan Pharmaceutical Holdings Group Ltd., Subsidiaries 44